This pattern is widely described by clinicians in the field, though the precise 'how often' figure is less firmly established than the pattern itself.

One frequently cited figure, that 1 in 4 women presenting with perimenopausal symptoms is offered an SSRI, could not be traced to a peer-reviewed source; the closest verified figure comes from a UK survey, not peer-reviewed, in which 23 percent of women given any treatment received antidepressants specifically. It's worth being clear that antidepressants are legitimate, evidence-based options for hot-flash-type symptoms in women who cannot or prefer not to use hormones, and perimenopausal clinical depression is real and deserves treatment. The documented concern from clinicians is reflexive substitution - prescribing an antidepressant as a default without ever discussing the hormonal context or offering hormone therapy as an option.

What to know about this answer

There's no real dispute that antidepressants have a legitimate place in menopause care, or that the reflexive-substitution pattern described by clinicians is real. The specific frequency of that pattern is the part that is not solidly measured.

What the research shows, and which source each finding rests on

A UK survey of about 5,000 women, not peer-reviewed, presented as a conference poster, found 79% had visited a GP with symptoms; among women given treatment, 37% received hormone therapy and 23% were given antidepressants; a subset attended more than 10 times before receiving adequate help.

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Reflexive substitution is a real, described pattern

clinicians including Dr. Corinne Menn, Dr. Heather Hirsch, and Dr. Avrum Bluming

Multiple clinicians independently describe patients being offered antidepressants, sleeping tablets, or migraine treatment symptom-by-symptom without the hormonal context ever being raised, and the one verifiable UK survey found antidepressants were the second most common treatment offered, after hormone therapy, among women who received any treatment at all.

The precise '1 in 4' frequency is unverified

a verification gap acknowledged directly in the source material

The specific figure that one in four women presenting with perimenopausal symptoms is offered an SSRI could not be traced to a peer-reviewed source and should be treated as an expert-cited estimate, not a confirmed statistic.

What would settle it: A peer-reviewed study directly measuring how often perimenopausal women presenting with vasomotor or mood symptoms are offered an antidepressant versus hormone therapy versus both, ideally alongside whether hormonal causes were discussed at all.

What is really going on here

  1. Was the antidepressant offered because I was assessed for depression specifically, or as a general response to my symptoms?
  2. Was hormone therapy discussed and ruled out, or never raised as an option?

Questions for your doctor

  1. Was I assessed for depression specifically, or is this being offered as a general symptom treatment?
  2. Is hormone therapy an option for me, and if not, why not?
  3. If I'm not interested in an antidepressant, what other evidence-based options exist for these specific symptoms?
  4. Can we discuss whether these symptoms might be connected to perimenopause rather than being treated as freestanding issues?

Questions with no answer yet

How often, in verified records rather than expert recollection, are perimenopausal women actually offered an antidepressant before hormone therapy is discussed at all?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The specific 'one in four' figure that circulates could not be traced to a peer-reviewed source. The closest verified figure comes from a non-peer-reviewed survey in which 23 percent of women given any treatment received antidepressants, a different measurement, share of treated women rather than share of all presenting women, than the circulating claim.

What would test it: A peer-reviewed study directly measuring how often perimenopausal women presenting with vasomotor or mood symptoms are offered an antidepressant versus hormone therapy versus both, ideally alongside whether hormonal causes were discussed at all.

When an antidepressant is prescribed for perimenopausal symptoms without a specific depression assessment, does it actually help those symptoms as much as it would for genuine major depression, or is its apparent benefit smaller in this context?

Partly studied

What is known: Antidepressants are legitimate, evidence-based options for hot-flash-type symptoms in women who cannot or prefer not to use hormones, a separate and established indication from treating major depression. Whether reflexive prescribing without a specific assessment produces the same benefit as either of those two evidence-based uses has not been directly measured.

What would test it: A study comparing outcomes in women prescribed antidepressants after a specific vasomotor or depression assessment against those prescribed reflexively without one, for the same presenting symptoms.

Sources

  1. 1.Newson Health Research and Education. Delayed diagnosis and treatment of menopause is wasting NHS resources (survey of approximately 5,000 UK women; British Menopause Society conference poster, 2021).Review, opinion or mechanism

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides